1-15 of 15
Authors: P. Gilabert
Journal Article
P1211 A faecal microbial signature, in combination with faecal calprotectin, to optimise endoscopic activity monitoring in Crohn’s Disease Free
Journal of Crohn's and Colitis, Volume 18, Issue Supplement_1, January 2024, Page i2142, https://doi.org/10.1093/ecco-jcc/jjad212.1341
Published: 24 January 2024
Journal Article
P386 Clinical presentation, management, and evolution of lymphomas in patients with Inflammatory Bowel Disease: an ENEIDA registry study. Free
Journal of Crohn's and Colitis, Volume 17, Issue Supplement_1, February 2023, Pages i519–i520, https://doi.org/10.1093/ecco-jcc/jjac190.0516
Published: 30 January 2023
Journal Article
P674 Definition of a microbial signature as a predictor of anti-TNFα treatment response Free
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Page S595, https://doi.org/10.1093/ecco-jcc/jjab076.794
Published: 27 May 2021
Journal Article
Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU Free
Journal of Crohn's and Colitis, Volume 15, Issue Supplement_1, May 2021, Pages S553–S554, https://doi.org/10.1093/ecco-jcc/jjab076.729
Published: 27 May 2021
Journal Article
P835 Correlation between microbial markers and faecal calprotectin in IBD patients Free
Journal of Crohn's and Colitis, Volume 14, Issue Supplement_1, January 2020, Page S648, https://doi.org/10.1093/ecco-jcc/jjz203.963
Published: 15 January 2020
Journal Article
P162 RAID-Monitor: a new non-invasive method to determine endoscopic activity in inflammatory bowel diseases Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S169–S170, https://doi.org/10.1093/ecco-jcc/jjy222.286
Published: 25 January 2019
Journal Article
P645 Pharmacokinetics and immunogenicity of Infliximab biosimilar in inflammatory bowel disease patients Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S441, https://doi.org/10.1093/ecco-jcc/jjy222.769
Published: 25 January 2019
Journal Article
P251 RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Page S222, https://doi.org/10.1093/ecco-jcc/jjy222.375
Published: 25 January 2019
Journal Article
P635 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease Get access
Journal of Crohn's and Colitis, Volume 13, Issue Supplement_1, March 2019, Pages S435–S436, https://doi.org/10.1093/ecco-jcc/jjy222.759
Published: 25 January 2019
Journal Article
P318 Association between faecal calprotectin values and infliximab trough levels in inflammatory bowel disease patients Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Pages S261–S262, https://doi.org/10.1093/ecco-jcc/jjx180.445
Published: 16 January 2018
Journal Article
P761 IFX dose-escalation strategy based on a population PK model in IBD patients with secondary loss of response Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Page S496, https://doi.org/10.1093/ecco-jcc/jjx180.888
Published: 16 January 2018
Journal Article
P213 RAID-IBS Diagnosis: A new non-invasive method to support Irritable Bowel Syndrome diagnosis Get access
Journal of Crohn's and Colitis, Volume 12, Issue supplement_1, February 2018, Page S207, https://doi.org/10.1093/ecco-jcc/jjx180.340
Published: 16 January 2018
Journal Article
P143 From biopsies to fecal samples: challenging Faecalibacterium prausnitzii and related phylogroups as potential biomarkers for IBD Get access
Journal of Crohn's and Colitis, Volume 11, Issue suppl_1, February 2017, Pages S148–S149, https://doi.org/10.1093/ecco-jcc/jjx002.269
Published: 26 January 2017
Journal Article
P201 A faecal bacterial markers correlates with Calprotectin for IBD activity monitoring? Get access
Journal of Crohn's and Colitis, Volume 11, Issue suppl_1, February 2017, Page S178, https://doi.org/10.1093/ecco-jcc/jjx002.326
Published: 26 January 2017
Journal Article
P546 Which are the optimal adalimumab trough levels associated with biological remission in patients with inflammatory bowel disease? Get access
Journal of Crohn's and Colitis, Volume 11, Issue suppl_1, February 2017, Page S358, https://doi.org/10.1093/ecco-jcc/jjx002.670
Published: 26 January 2017
